Terkko Navigator / Movement Disorders

TWNK in Parkinson's Disease: A Movement Disorder and Mitochondrial Disease Center Perspective Study

Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?

European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene

Striatal Blood–Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study

Coherent Structural and Functional Network Changes after Thalamic Lesions in Essential Tremor

A 10‐Year Community‐Based Study of Leucine‐Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease

Neurodevelopmental Gene‐Related Dystonia‐Parkinsonism with Onset in Adults: A Case with NAA15 Variant

Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms

Highlighting the Dystonic Phenotype Related to GNAO1

Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine

Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s Disease

Erratum to“Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Approach”

Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene

Striatal Blood–Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study

Coherent Structural and Functional Network Changes after Thalamic Lesions in Essential Tremor

A 10‐Year Community‐Based Study of Leucine‐Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease

Neurodevelopmental Gene‐Related Dystonia‐Parkinsonism with Onset in Adults: A Case with NAA15 Variant

Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms

Highlighting the Dystonic Phenotype Related to GNAO1

Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine

Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s Disease

Cortical and Subthalamic Nucleus Spectral Changes During Limb Movements in Parkinson's Disease Patients with and Without Dystonia

The Impact of Type 2 Diabetes in Parkinson's Disease

Adult‐Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERDND): Time to Move Beyond the Skin

“On Chorea”: 150 Years of the Beginning of Hope

COVID‐19 Infection Enhances Susceptibility to Oxidative Stress–Induced Parkinsonism

Is Gait Dysfunction a Prominent Sign of Isolated Rapid Eye Movement Sleep Behavior Disorder?

Is Gait Dysfunction a Prominent Sign of Isolated Rapid Eye Movement Sleep Behavior Disorder?

Cannabinoid Receptor Type 1 in Parkinson's Disease: A Positron Emission Tomography Study with [18F]FMPEP‐d2

Cannabinoid Receptor Type 1 in Parkinson's Disease: A Positron Emission Tomography Study with [18F]FMPEP‐d2

Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy

Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy

Abstracts

Cover Image

Mutation Screening of TFG inα‐Synucleinopathy and Amyotrophic Lateral Sclerosis

Beekeeper Parkinsonism

A Cautionary Tale of Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy‐Induced White Matter Lesions

Corticobasal Syndrome with TAR Binding Protein 43–Positive Oligodendrocyte Inclusions

Genetic Determinants of Survival in Parkinson's Disease in the Asian Population

Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage

Parkinson's Disease Is Associated with Impaired Gut–Blood Barrier for Short‐Chain Fatty Acids

Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study

Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's Disease

Letter on Proposals for Gait Research